Donor killer-cell immunoglobulin-like receptor (KIR) genotype does not improve graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) after unrelated donor transplant: a CIBMTR analysis

Allogeneic hematopoietic cell transplantation (alloHCT) remains the sole curative therapy for patients with CLL leading to 40–45% long-term survival. The impact of donor KIR genotype on outcomes of unrelated donor (URD) alloHCT for CLL is unknown. METHODS: We examined 573 adult (URD)-CLL recipient p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Bachanova, Veronika, Weisdorf, Daniel J., Wang, Tao, Marsh, Steven G.E., Cereb, Nezih, Haagenson, Michael D, Spellman, Stephen R., Lee, Stephanie J., Guethlein, Lisbeth A., Parham, Peter, Miller, Jeffrey S., Cooley, Sarah A.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511301/
https://ncbi.nlm.nih.gov/pubmed/30594542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.12.763
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars